Prediction of Maximum Exposure in Poor Metabolizers Following Inhibition of Nonpolymorphic Pathways

E-ISSN： 1875-5453|7|3|295-299

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.7, Iss.3, 2006-04, pp. : 295-299

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers

By Pedersen Rasmus Steen Damkier Per Brøsen Kim

European Journal of Clinical Pharmacology, Vol. 62, Iss. 7, 2006-07 ,pp. : 513-521

Springer Publishing Company

Access to resources Recommend Favorite

[ 3 H]GBR 12935 binding in platelets from poor and extensive cytochrome P-4502D6 metabolizers

By Norlen M. Norstrom A. Spigset O. Allard P.

European Journal of Pharmacology, Vol. 366, Iss. 2, 1999-02 ,pp. : 329-332

Elsevier

Access to resources Recommend Favorite

Finasteride 1 mg has no inhibitory effect on omeprazole metabolism in extensive and poor metabolizers for CYP2C19 in Japanese

By Yasumori T. Narita H. Matsuda T. Takubo T. Ogawa M. Ishii M. Hara K. Ishii Y. Okuyama K. Fujimoto G. Ochiai H. Kano A. Hasegawa S. Sato K. Taniguchi T.

European Journal of Clinical Pharmacology, Vol. 62, Iss. 11, 2006-11 ,pp. : 939-946

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of Venlafaxine Extended Release 75 mg and Desvenlafaxine 50 mg in Healthy CYP2D6 Extensive and Poor Metabolizers: A Randomized, Open-Label, Two-Period, Parallel-Group, Crossover Study

By Nichols Alice I.

Clinical Drug Investigation, Vol. 31, Iss. 3, 2011-03 ,pp. : 155-167

Adis International

Access to resources Recommend Favorite

Prediction Oriented QSAR Modelling of EGFR Inhibition

Current Medicinal Chemistry, Vol. 13, Iss. 3, 2006-02 ,pp. : 277-287

Bentham Science Publishers

Access to resources Recommend Favorite